Since the development of functional magnetic resonance imaging in the 1990s, the reliance on neuroimaging has skyrocketed as researchers investigate how fMRI data from the brain at rest, and ...

Grey Matters Health Inc. (the “Company” or “Grey Matters”) (CSE: GREY) (FRANKFURT: AGW0) (OTC: AGNPF), a Canadian healthcare ...

Until recently, getting an MRI meant traveling to the hospital. But a new generation of more affordable and highly portable MRI (pMRI) devices are rapidly reshaping neuroimaging research and clinical ...

Schizophrenia is a chronic mental health disorder characterized by hallucinations, delusions, disorganized thinking and atypical movement or speech patterns. This psychiatric condition can be highly ...

Neuroimaging technology has been shown to hold great promise in helping clinicians link specific symptoms of mental health disorders to abnormal patterns of brain activity. But a new study shows there ...

This Collection supports and amplifies research related to SDG 3. Neuroimaging and genetics are critical data modalities that inform our scientific understanding of dementia pathophysiology, serve as ...

Repetitive transcranial magnetic stimulation, or rTMS, was FDA approved in 2008 as a safe and effective noninvasive treatment for severe depression resistant to antidepressant medications. A small ...

A literature review in Harvard Review of Psychiatry indicates that, while transcranial electrical stimulation (tES) has rarely been used in treating visual hallucinations (VH) among patients with ...

Stroke and transient ischemic attack (TIA) are major cerebrovascular events that can lead not only to physical disability but also to substantial ...

LOS ANGELES--(BUSINESS WIRE)--Kernel, a leader in non-invasive neuroimaging, announces the publication of their study "Measuring acute effects of subanesthetic ketamine on cerebrovascular hemodynamics ...